PCN474 MAPPING PATIENT INVOLVEMENT IN NICE APPRAISALS OF ONCOLOGY PRODUCTS
نویسندگان
چکیده
منابع مشابه
Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives?
CONTEXT The National Institute for Health and Care Excellence (NICE) has an explicit mandate to include patient and public involvement in the appraisal of medicines to be available for funding on the NHS. NICE involves an appraisal committee who are required to take on board experiential evidence from patient experts alongside population-based evidence on clinical and cost-effectiveness when ma...
متن کاملBrain mapping in Neurosurgical oncology
After the introduction of MRI, new modalities facilitated the procedure of surgical planning to achieve the microsurgical goal and improve prognosis and quality of life in patients. Despite the variable applications of preoperative and intraoperative mapping and monitoring systems, several limitations and concerns are reported for every modality as well. In this issue of the IrJNS, we are delig...
متن کاملAssessing searches in NICE single technology appraisals: practice and checklist.
OBJECTIVES No guidelines exist in the approach that Evidence Review Groups (ERGs) should take to appraise search methodologies in the manufacturer's submission (MS) in Single Technology Appraisals (STA). As a result, ERGs are left to appraise searches using their own approach. This study investigates the limitations of manufacturers' search methodologies as critiqued by ergs in published sta re...
متن کاملBiologic agents for rheumatoid arthritis—negotiating the NICE technology appraisals
In England and Wales, the National Institute for Health and Clinical Excellence (NICE) has provided guidance [technology appraisals (TAs) 130, 186, 195, 198 and 225] on the use of biologic drugs for the treatment of RA. This is based on an analysis of efficacy, safety and cost-effectiveness, and has resulted in a complex management pathway that restricts freedom to prescribe biologics according...
متن کاملCapturing all of the costs in NICE appraisals: the impact of inflammatory rheumatic diseases on productivity.
Inflammatory rheumatic diseases are common. It is estimated that ∼2.1% of the population has an inflammatory rheumatic disease (Andrianakos A, Trontzas P, Christoyannis F et al. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. J Rheumatol 2003;30:1589-601). For diseases such as RA, PsA and AS, onset is most frequent between...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2019
ISSN: 1098-3015
DOI: 10.1016/j.jval.2019.09.666